Get started
Author

Masahiro Sekimizu

Observed names: M Sekimizu, M. Sekimizu, MASAHIRO SEKIMIZU, Sekimizu, Masahiro
Observed institutions: Kanagawa Children's Medical Center, National Hospital Organization, Japanese Red Cross Narita Hospital, Nagoya Medical Center, Nagoya University, Pharmaceuticals and Medical Devices Agency
ORCID: 0000-0002-9438-2673
Observed ORCID: 0000-0002-9438-2673
OpenAlex ID: A5075893893
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial
2020 · Reiji Fukano, Tetsuya Mori, et al. · Cancer Science · 109
PDF
Chromosome abnormalities in advanced stage T‐cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature
2011 · Masahiro Sekimizu, Shosuke Sunami, et al. · British Journal of Haematology · 42
Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study
2015 · Shosuke Sunami, Masahiro Sekimizu, et al. · Pediatric Blood & Cancer · 26
A Case of NUT Midline Carcinoma With Complete Response to Gemcitabine Following Cisplatin and Docetaxel
2013 · Hideaki Ueki, Naoko Maeda, et al. · Journal of Pediatric Hematology/Oncology · 26
Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial
2025 · Hiroto Shimokawahara, Mari Nishizaki, et al. · The Lancet Respiratory Medicine · 13
PDF
Characteristics of genetic alterations of peripheral T‐cell lymphoma in childhood including identification of novel fusion genes: the Japan Children’s Cancer Group (JCCG)
2021 · Kentaro Ohki, Nobutaka Kiyokawa, et al. · British Journal of Haematology · 13
PDF
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
2018 · Masahiro Sekimizu, Tomoo Osumi, et al. · PubMed · 13
PDF
Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial.
2017 · Hirokazu Nagai, Reiji Fukano, et al. · PubMed · 13
Osteosarcoma After Bone Marrow Transplantation
2013 · Hideaki Ueki, Naoko Maeda, et al. · Journal of Pediatric Hematology/Oncology · 13
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
2022 · Tsuyoshi Matsumura, Hiroya Hashimoto, et al. · Orphanet Journal of Rare Diseases · 12
PDF
Association between sites and severity of eczema and the onset of cow’s milk and egg allergy in children
2020 · Shiori Kawada, Masaki Futamura, et al. · PLoS ONE · 12
PDF
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol
2018 · Masahiro Sekimizu, Akihiro Iguchi, et al. · BMC Cancer · 11
PDF
Treatment of pediatric lymphoma in Japan: Current status and plans for the future
2015 · Ryoji Kobayashi, Shosuke Sunami, et al. · Pediatrics International · 11
Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib
2013 · Masahiro Sekimizu, Yuka Yamashita, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin‐Frankfurt‐Münster (BFM)95‐based protocol
2021 · Kunihiko Moriya, Toshihiko Imamura, et al. · British Journal of Haematology · 9
PDF
Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol
2019 · Taku Nakagawa, Hiroya Hashimoto, et al. · BMJ Open Respiratory Research · 9
PDF
Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature
2016 · Takeo Sarashina, Haruko Iwabuchi, et al. · International Journal of Hematology · 9
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)
2022 · Hideki Nakayama, Chitose Ogawa, et al. · International Journal of Hematology · 8
Study Protocol for a Multicenter, Open-Label, Single-Arm Study of Tranilast for Cardiomyopathy of Muscular Dystrophy
2019 · TSUYOSHI MATSUMURA, HIROYA HASHIMOTO, et al. · The Kurume Medical Journal · 8
PDF
Analysis of Japanese registration from the randomized international trial for childhood anaplastic large cell lymphoma (ALCL99-R1).
2014 · Tetsuya Mori, Reiji Fukano, et al. · PubMed · 8
Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: a single-arm, open-label, multicenter study
2025 · Tsuyoshi Matsumura, Takayasu Fukudome, et al. · Orphanet Journal of Rare Diseases · 7
PDF
Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma
2024 · Hisashi Ishida, Toshihiko Imamura, et al. · Cancer Medicine · 7
Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial)
2023 · Hiroto Shimokawahara, Takumi Inami, et al. · BMJ Open · 7
PDF
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study
2017 · Reiji Fukano, Shosuke Sunami, et al. · Journal of Pediatric Hematology/Oncology · 7
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
2015 · Masahiro Sekimizu, Tetsuya Mori, et al. · Pediatric Blood & Cancer · 7
Works count: 65
Citation count: 477
H-index: 11
I10-index: 14
Year
Topic
Type